Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
1(7%)
Results Posted
50%(6 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
2
14%
Ph phase_1
1
7%
Ph phase_4
3
21%
Ph phase_2
5
36%
Ph phase_3
2
14%

Phase Distribution

1

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
5(38.5%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(12)
Terminated(1)

Detailed Status

Completed12
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 25 (38.5%)
Phase 32 (15.4%)
Phase 43 (23.1%)
N/A2 (15.4%)

Trials by Status

terminated17%
completed1286%
recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
completednot_applicable

Tapentadol vs Pregabalin for Postoperative Pain in Lower Limb Surgery

NCT07587645
completednot_applicable

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

NCT07320781
recruitingphase_4

Tapentadol vs Tramadol in Total Knee Arthroplasty

NCT06269770
completedphase_3

Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo

NCT02604446
completedphase_2

Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.

NCT01725087
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07587645Not Applicable

Tapentadol vs Pregabalin for Postoperative Pain in Lower Limb Surgery

Completed
NCT07320781Not Applicable

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Completed
NCT06269770Phase 4

Tapentadol vs Tramadol in Total Knee Arthroplasty

Recruiting
NCT02604446Phase 3

Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo

Completed
NCT01725087Phase 2

Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.

Completed
NCT01729728Phase 2

Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain

Completed
NCT01435577Phase 2

Intravenous Tapentadol in Post-Bunionectomy Pain

Completed
NCT00983073Phase 3

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic

Completed
NCT03314792Phase 4

Effects of Tapentadol Versus Oxycodone After Hysterectomy.

Completed
NCT02221674Phase 2

Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

Terminated
NCT01946555

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

Completed
NCT01124617Phase 2

A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia

Completed
NCT01877226Phase 1

Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants

Completed
NCT01500317Phase 4

Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14